Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC: FLAURA

被引：0

作者：

Ramalingam, S. ^{[1
]}

Reungwetwattana, T. ^{[2
]}

Chewaskulyong, B. ^{[3
]}

Dechaphunkul, A. ^{[4
]}

Lee, K. H. ^{[5
]}

Imamura, F. ^{[6
]}

Nogami, N. ^{[7
]}

Ohe, Y. ^{[8
]}

Cheng, Y. ^{[9
]}

Cho, B. C. ^{[10
]}

Cho, E. K. ^{[11
]}

Vansteenkiste, J. F. ^{[12
]}

Voon, P. J. ^{[13
]}

Zhou, C. ^{[14
]}

Gray, J. ^{[15
]}

Hodge, R. ^{[16
]}

Rukazenkov, Y. ^{[17
]}

Soria, J-C. ^{[18
,19
]}

机构：

[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand

[3] Chiang Mai Univ, Dept Med, Oncol Unit, Chiang Mai, Thailand

[4] Prince Songkla Univ, Div Med Oncol, Internal Med, Hat Yai, Thailand

[5] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Div Med Oncol, Coll Med, Cheongju, South Korea

[6] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan

[7] Natl Hosp Org, Dept Thorac Oncol, Shikoku Canc Ctr, Matsuyama, Ehime, Japan

[8] Natl Canc Ctr, Dept Internal Med, Tokyo, Japan

[9] Jilin Canc Hosp, Med Oncol, Changchun, Jilin, Peoples R China

[10] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr,Coll Med, Yonsei, South Korea

[11] Gachon Univ, Div Hematol & Oncol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea

[12] Univ Hosp KU Leuven, Resp Oncol Unit Pulmonol, Leuven, Belgium

[13] Hosp Umum Sarawak, Radiotherapy & Oncol, Kuching, Malaysia

[14] Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China

[15] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA

[16] AstraZeneca, Biostat & Informat, Cambridge, England

[17] AstraZeneca, Res & Dev, Cambridge, England

[18] Dept Drug Dev, Gustave Roussy Canc Campus, Villejuif, France

[19] Univ Paris Sud, Villejuif, France

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA2_PR

引用

页数：1